Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Forslund

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
The British Journal of Dermatology|February 3, 2016
Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB-IVA mycosis fungoides/Sézary syndromeF Child, P L Ortiz-Romero, R Alvarez, et al.
Pediatric Obesity|February 17, 2020
A 6-month randomized, double-blind, placebo-controlled trial of weekly exenatide in adolescents with obesityD Weghuber, A Forslund, H Ahlström, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
The British Journal of Dermatology|February 3, 2016
Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB-IVA mycosis fungoides/Sézary syndromeF Child, P L Ortiz-Romero, R Alvarez, et al.
Pediatric Obesity|February 17, 2020
A 6-month randomized, double-blind, placebo-controlled trial of weekly exenatide in adolescents with obesityD Weghuber, A Forslund, H Ahlström, et al.
Pageof 4